A new multicenter study by researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with the National Cancer Institute-funded Clinical Proteomic Tumor Analysis Consortium (CPTAC) ...

Arsen Juric, Mozambique imPACT Review Coordinator said: “These preparatory meetings are part of a strategic process. They ...

Patients with advanced skin cancer in England are set to be fast-tracked into trials of a new cancer vaccine, following the expansion of a world-leading NHS programme. The needle-free injection, which ...

For his 44th birthday, just one month ago, Bobby Jenks asked his family to buy him a tent. It was a gift he knew he couldn’t ...

The US giants which supply vital new medicines to UK patients face disruption from Donald Trump’s trade barriers, experts ...

A saliva test may help "turn the tide" on prostate cancer, UK scientists claim. It analyses men's DNA to work out who was ...

More than 7 million people in Australia were born overseas. Some 5.8 million people report speaking a language other than ...

Recursion Pharmaceuticals—a relatively small company backed by the chip giant Nvidia—is betting that its massive ...

A new study from Lund University in Malmö, Sweden, revealed that waist circumference is a stronger risk indicator for obesity-related cancers in men than Body Mass Index (BMI). The research ...

Vaccination campaigns have nearly eradicated some of the most deadly and transmissible diseases. In a rising tide of vaccine ...

and is the second primary cause of deaths associated with cancer around the world. In the United States, CRC ranks as the second-most common cause of cancer-related deaths, following lung cancer.

The NIH is the world's leading medical research agency and largest funder of cancer research ... canceled hundreds of NIH grants to scientists around the country. Across HHS, nearly a quarter ...